To create a benchmark for the use of TAVR for aortic stenosis treatment in low-risk patients, this study evaluated outcomes of similar patients undergoing SAVR. The STS database was used to isolate low-risk SAVR patients from 2011–2019.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
TAVR (TAVI)
October 20, 2023
September 26, 2023
This video demonstrates the authors’ step-by-step method for transaxillary TAVI.
August 24, 2023
During some transcatheter aortic valve implant (TAVI) procedures, complications require conversion to emergency open heart surgery (E-OHS). This study evaluated early and midterm outcomes in a large center over fifteen years. Patients were grouped by surgical risk and the study time was divided into three five-year periods.
July 27, 2023
In forty-eight consecutive patients undergoing explants of transcatheter aortic valve replacement (TAVR) at a single center between 2011 and 2021, at a median of 2.3 years after TAVR, the most common indications for surgery were nonstructural valve dysfunction (patient-prosthesis mismatch or paravalvular leak) in 35 percent, structural valve deterior
June 29, 2023
Recently, a minimal approach to transcatheter valve replacement using only local anesthesia has been used to promote a faster procedure and recovery time. With this lack of general anesthesia, however, comes more anxiety and the possibility of pain for patients.
June 29, 2023
Transcatheter aortic valve implantation (TAVI) is now a standard procedure for the treatment of symptomatic aortic valve stenosis in many patients.
February 23, 2023
A new study found that patients who undergo TAVR with concomitant chronic total occlusion lesions are more likely to experience complications from the procedure, but they do not have a higher risk of mortality. The results suggest that if a patient is otherwise a candidate for TAVR, their CTO status should not exclude them from the surgery.
January 27, 2023
A novel self-expanding TAVR valve has been successfully implanted in ten patients, as reported by a research team in China. The new device is made of a self-expanding nitinol stent with three valve leaflets of bovine pericardial, reduces the risk of coronary obstruction, and is completely retrievable and repositionable.
January 12, 2023
INTEGRITTY, a group dedicated the appraisal of evidence to support optimized patient management, published a paper highlighting concerns surrounding major TAVR versus SAVR studies. While their findings do not aim to directly discredit the studies, they do raise questions about the integrity of their methodology.
December 21, 2022
A comparative study between five types of transcatheter heart valves found that although adverse outcome rates are low among all devices, some differences do stand out.